Võrdle meetodeid

	Gastro-pareaasi sümptomite indeks	GERD Health-Related Quality of Life Scale	Simple Clinical Colitis Activity Index
Valdkond	Gastroenteroloogia	Gastroenteroloogia	Gastroenteroloogia
Perekond	Process / pipeline	Process / pipeline	Process / pipeline
Tekkeaasta	2003	1996	1998
Looja	Revicki, D. A., Rentz, A. M., Dubois, D., et al.	Velanovich, V., Zhang, Y., Hollis, J. B., et al.	Walmsley, R. S., Ayres, R. C., Pounder, R. E., and Allan, R. N.
Tüüp	Self-report	Self-report	Clinician-rated
Algallikas	Revicki, D. A., Rentz, A. M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N. J., & Tack, J. (2003). Development and validation of a patient-assessed gastroparesis symptom severity index. Alimentary Pharmacology & Therapeutics, 18(1), 141–150.	Velanovich, V., Zhang, Y., Hollis, J. B., Feldman, M. I., Sampliner, R., Guan, W., & Escamilla, C. (1996). Presenting symptoms and outcome measures in reflux esophagitis. Digestive Diseases and Sciences, 41(10), 1865–1873.	Walmsley, R. S., Ayres, R. C., Pounder, R. E., & Allan, R. N. (1998). A simple clinical colitis activity index. Gut, 43(1), 29–32.
Rööpnimetused	GCSI	GERD-HRQL, GERD-HRQoL	SCCAI
Seotud	4	4	4
Kokkuvõte	The Gastroparesis Cardinal Symptom Index (GCSI) is a validated, patient-reported outcome measure specifically designed to assess symptom severity in gastroparesis. Developed by Revicki and colleagues in 2003, the GCSI captures the three cardinal symptom clusters of gastroparesis: nausea and vomiting, postprandial fullness, and early satiety, plus bloating and stomach distension. The 9-item questionnaire is responsive to treatment changes and is increasingly used in clinical trials and practice to monitor gastroparesis progression and therapy response.	The GERD Health-Related Quality of Life Scale (GERD-HRQL) is a concise, validated patient-reported outcome measure for assessing the symptomatic and functional impact of gastroesophageal reflux disease (GERD). Developed by Velanovich and colleagues in 1996, the 9-item GERD-HRQL measures heartburn frequency and severity, regurgitation, and impact on sleep and medication use. The scale is highly responsive to proton pump inhibitor (PPI) therapy and is widely used in GERD trials and clinical practice.	The Simple Clinical Colitis Activity Index (SCCAI) is a practical, bedside tool for assessing disease activity in ulcerative colitis and colonic Crohn's disease. Published in 1998 by Walmsley and colleagues, the SCCAI condenses disease assessment into six items that can be administered in a office visit without laboratory or endoscopic data. It provides rapid, reproducible quantification of disease severity and is ideal for frequent monitoring in routine clinical practice.